Ahmet Eroglu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmet Eroglu has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
Nesrin Erciyes
4 shared publicationsHalil Uzunlar
3 shared publications- Ahmet Oğuzhan Küçük
Division of Intensive Care Medicine, Department of Pulmonary Medicine, Faculty of Medicine, Karadeniz Technical University, Trabzon, Türkiye
2 shared publications - Engin Erturk
Faculty of Medicine, Department of Anesthesiology and Intensive Care, Karadeniz Technical University, Trabzon, Turkey
2 shared publications - Çağdaş Alp Uzan
Ordu Public Hospital, Ordu, Turkey
2 shared publications - Ümran Karaca
Department of Anesthesiology and Reanimation University of Health Sciences Bursa Yüksek İhtisas Training and Research Hospital Bursa Turkey
2 shared publications
Latest Publications
- 1 April 2025
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 91 (3)
Can estazolam plus remimazolam as an anxiolytic reduce remifentanil-induced postoperative hyperalgesia?
Article: Can estazolam plus remimazolam as an anxiolytic reduce remifentanil-induced postoperative hyperalgesia? - Minerva Anestesiologica 2025 Jan 30 - Minerva Medica - Journals
- 1 April 2025
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 91 (3)
Can estazolam plus remimazolam as an anxiolytic reduce remifentanil-induced postoperative hyperalgesia?
Article: Can estazolam plus remimazolam as an anxiolytic reduce remifentanil-induced postoperative hyperalgesia? - Minerva Anestesiologica 2025 Jan 30 - Minerva Medica - Journals
- Open Access
- 22 November 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 11-16
Evaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study
COVID-19,intensive care,intensive care unit,pandemic,follow-up
- 22 November 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 25 (1) , 11-16
Open AccessEvaluation of Patients with COVID-19 Followed Up in Intensive Care Units in the Second Year of the Pandemic: A Multicenter Point Prevalence Study
COVID-19,intensive care,intensive care unit,pandemic,follow-up
- 30 June 2023
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 2 (2) , 23-26
Yoğun Bakım Ünitesinde Valproik Asit Kaynaklı Ciddi Toksisite Tedavisinde Hemodiyaliz, Levokarnitin ve Meropenem Uygulaması
Giriş: Valproik asit (VPA) günümüzde epilepsi, bipolar bozukluk, şizoafektif bozukluk, şizofreni ve migren profilaksisinde kullanılabilen bir ilaçtır. Valproik asit zehirlenmesi merkezi sinir sistemi depresyonu, şok, akut hiperammonemi, beyin ödemi, koma ve ölümle sonuçlanabilir. Bu olguda şiddetli VPA toksisitesi nedeniyle levokarnitin, hemodiyaliz ve meropenem tedavisi uyguladığımız bir hastayı sunmak istedik. Olgu: 41 yaşında erkek hasta önce acil servise sonrasında Yoğun Bakım Ünitesi’ne bilinç bulanıklığıyla getirildi. Glasgow Koma Skoru 6 ve solunumu yetersiz olduğu için entübe edildi. Hastanın taşikardisi, hipotansiyonu, vasopressor ilaç ihtiyacı vardı. Karaciğer fonksiyon testleri normal bulunurken, hiperammoneminin ilaca bağlı olduğu düşünüldü. Hastanın kan valproat düzeyi 1055mg/L (terapötik normal aralık: 50-100mg/L) bulundu. Aspirasyon Pnömonisi gelişen hastaya valproik asit intoksikasyonunda yararlı olduğu saptanan meropenem verildi. Valproik asit zehirlenmesinin klinik belirtileri, merkezi sinir sistemi depresyonu, solunum depresyonu, hipotansiyon, metabolik asidoz, kemik iliği yetmezliği, beyin ödemi, hipoglisemi, hipernatremi ve hiperamonyemidir. Akut valproik asit zehirlenmesinin tedavisi genellikle destekleyici tedavi ve sıvı tedavisi, vazopresör desteği, elektrolit dengesizliği ve asit-baz bozukluklarının düzeltilmesini içerir. Olgumuzda başlangıç valproat düzeyi 1055 uq/ml olduğu için ilk tedavi olarak hemodiyalize başvurduk. Levokarnitin özellikle hiperammonemide yararlı olabileceğinden kullandık. Sonuç: Sonuç olarak hemodiyaliz, levokarnitin ve meropenem kombine tedavisinin valproik asit düzeyini hızla düşürdüğü ve başarılı bir şekilde iyileşme sağladığını gözlemledik.
- 30 June 2023
- Published by Tıp Fakültesi, Karadeniz Teknik Üniversitesi in Farabi Tıp Dergisi
- Vol. 2 (2) , 23-26
Yoğun Bakım Ünitesinde Valproik Asit Kaynaklı Ciddi Toksisite Tedavisinde Hemodiyaliz, Levokarnitin ve Meropenem Uygulaması
Giriş: Valproik asit (VPA) günümüzde epilepsi, bipolar bozukluk, şizoafektif bozukluk, şizofreni ve migren profilaksisinde kullanılabilen bir ilaçtır. Valproik asit zehirlenmesi merkezi sinir sistemi depresyonu, şok, akut hiperammonemi, beyin ödemi, koma ve ölümle sonuçlanabilir. Bu olguda şiddetli VPA toksisitesi nedeniyle levokarnitin, hemodiyaliz ve meropenem tedavisi uyguladığımız bir hastayı sunmak istedik. Olgu: 41 yaşında erkek hasta önce acil servise sonrasında Yoğun Bakım Ünitesi’ne bilinç bulanıklığıyla getirildi. Glasgow Koma Skoru 6 ve solunumu yetersiz olduğu için entübe edildi. Hastanın taşikardisi, hipotansiyonu, vasopressor ilaç ihtiyacı vardı. Karaciğer fonksiyon testleri normal bulunurken, hiperammoneminin ilaca bağlı olduğu düşünüldü. Hastanın kan valproat düzeyi 1055mg/L (terapötik normal aralık: 50-100mg/L) bulundu. Aspirasyon Pnömonisi gelişen hastaya valproik asit intoksikasyonunda yararlı olduğu saptanan meropenem verildi. Valproik asit zehirlenmesinin klinik belirtileri, merkezi sinir sistemi depresyonu, solunum depresyonu, hipotansiyon, metabolik asidoz, kemik iliği yetmezliği, beyin ödemi, hipoglisemi, hipernatremi ve hiperamonyemidir. Akut valproik asit zehirlenmesinin tedavisi genellikle destekleyici tedavi ve sıvı tedavisi, vazopresör desteği, elektrolit dengesizliği ve asit-baz bozukluklarının düzeltilmesini içerir. Olgumuzda başlangıç valproat düzeyi 1055 uq/ml olduğu için ilk tedavi olarak hemodiyalize başvurduk. Levokarnitin özellikle hiperammonemide yararlı olabileceğinden kullandık. Sonuç: Sonuç olarak hemodiyaliz, levokarnitin ve meropenem kombine tedavisinin valproik asit düzeyini hızla düşürdüğü ve başarılı bir şekilde iyileşme sağladığını gözlemledik.
- 9 December 2022
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 21 (4) , 277-280
Successful Management of Severe Verapamil Overdose with VAECMO
- 9 December 2022
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 21 (4) , 277-280
Successful Management of Severe Verapamil Overdose with VAECMO
- 22 September 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (3) , 349-359
Effects of personality traits on severity of sepsis
Introduction: The aim of this study was to reveal the effect of the individual's lifestyle and personality traits on the disease process in patients with sepsis and to have clinical predictions about these patients. Materials and Methods: The study was planned as a multi-center, prospective, observational study after obtaining the approval of the local ethics committee. Patients were hospitalized in different intensive care units. Besides demographics and personal characteristics of patients, laboratory data, length of hospital and ICU stay, and mortality was recorded. Two hundred and fifty-nine patients were followed up in 11 different intensive care units. Mortality rates, morbidities, blood analyses, and personality traits were evaluated as primary outcomes. Results: Of the 259 patients followed up, mortality rates were significantly higher in men than in women (p=0.008). No significant difference was found between the patients' daily activity, tea and coffee consumption, reading habits, smoking habits, blood groups, atopy histories and mortality rates. Examining the personal traits, it was seen that 90 people had A-type personality structure and 51 (56.7%) of them died with higher mortality rate compared to type B (p=0.038). There was no difference between personalities, in concomitant ARDS occurrence, need for sedation and renal replacement therapies. Conclusion: Among individuals diagnosed with sepsis/septic shock, mortality increased significantly in patients with A-type personality trait compared to other personality traits. These results showed that personal traits may be useful in predicting the severity of disease and mortality in patients with sepsis/septic shock.
- 22 September 2021
- Published by Bilimsel Tip Publishing House in Tuberk Toraks
- Vol. 69 (3) , 349-359
Effects of personality traits on severity of sepsis
Introduction: The aim of this study was to reveal the effect of the individual's lifestyle and personality traits on the disease process in patients with sepsis and to have clinical predictions about these patients. Materials and Methods: The study was planned as a multi-center, prospective, observational study after obtaining the approval of the local ethics committee. Patients were hospitalized in different intensive care units. Besides demographics and personal characteristics of patients, laboratory data, length of hospital and ICU stay, and mortality was recorded. Two hundred and fifty-nine patients were followed up in 11 different intensive care units. Mortality rates, morbidities, blood analyses, and personality traits were evaluated as primary outcomes. Results: Of the 259 patients followed up, mortality rates were significantly higher in men than in women (p=0.008). No significant difference was found between the patients' daily activity, tea and coffee consumption, reading habits, smoking habits, blood groups, atopy histories and mortality rates. Examining the personal traits, it was seen that 90 people had A-type personality structure and 51 (56.7%) of them died with higher mortality rate compared to type B (p=0.038). There was no difference between personalities, in concomitant ARDS occurrence, need for sedation and renal replacement therapies. Conclusion: Among individuals diagnosed with sepsis/septic shock, mortality increased significantly in patients with A-type personality trait compared to other personality traits. These results showed that personal traits may be useful in predicting the severity of disease and mortality in patients with sepsis/septic shock.
- Open Access
- 22 March 2021
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 8 (3) , 150-154
Cranial hyperthermia resulting from decreased parotid gland salivation induced by ischemic degeneration of glossopharyngeal network in subarachnoid hemorrhage
Objective: We speculated that subarachnoid hemorrhage (SAH) induces ischemic lesions in the cranial parasympathetic nerves, which may decrease saliva secretion and lead to hyperthermia. We tested this hypothesis by examining histologic features of parotid glands and glossopharyngeal nerves (GPNs) in a rabbit model of SAH. Material and Methods: Rabbits (n = 25) were divided into control (n = 5), sham (n = 5), and SAH (n = 15) groups. Animals in the sham and SAH groups were examined over a 3-week period before sacrifice. Salivation score (SC) was determined by measuring the mean wetted area of an orally inserted cotton ball. Sections of parotid glands and intracranial and intraparotideal branches of the GPNs were stained with hematoxylin and eosin and SAH-induced damage was analyzed by terminal deoxynucleotidyl transferase dUTP nick end labeling of apoptotic cells. Specimens were stereologically examined to determine saliva-filled total vesicle volume (TVV) per cubic meter; vasospasm index (VSI) based on wall/lumen ratio of parotid glands arteries, and degenerated neuron density (DND) of glossopharyngeal ganglia. Results: The mean oral temperature was 36.9°C. In the control group, mean values were as follows: SC, 46±8 mm2; DND, 19±4/mm3; VSI, 1.065±0.049; and TVV, (780±1187) × 106/µm3. In the sham group, mean values were as follows: SC, 31±6 mm2; DND, 98±23/mm3; VSI, 1.67±0.32; and TVV, (617±110) × 106/µm3. In the low hyperthermia SAH group, mean values were as follows: SC, 16±5 mm2; DND, 1520±261/mm3; VSI, 2.12±0.21, and TVV, (314±98) × 106/µm3. In the high hypothermia SAH group, mean values were as follows: SC, 9±2 mm2; DND, 3210±912/mm3; VSI, 3.18±0.30; and TVV, (432±99) × 106/µm3. Conclusions: Decreased salivary secretion due to secretory gland atrophy originated from ischemia-induced GPN network degeneration at the brainstem, which may be responsible for cranial hyperthermia following SAH.
- 22 March 2021
- Published by Lycia Press London UK in Medical Science and Discovery
- Vol. 8 (3) , 150-154
Open AccessCranial hyperthermia resulting from decreased parotid gland salivation induced by ischemic degeneration of glossopharyngeal network in subarachnoid hemorrhage
Objective: We speculated that subarachnoid hemorrhage (SAH) induces ischemic lesions in the cranial parasympathetic nerves, which may decrease saliva secretion and lead to hyperthermia. We tested this hypothesis by examining histologic features of parotid glands and glossopharyngeal nerves (GPNs) in a rabbit model of SAH. Material and Methods: Rabbits (n = 25) were divided into control (n = 5), sham (n = 5), and SAH (n = 15) groups. Animals in the sham and SAH groups were examined over a 3-week period before sacrifice. Salivation score (SC) was determined by measuring the mean wetted area of an orally inserted cotton ball. Sections of parotid glands and intracranial and intraparotideal branches of the GPNs were stained with hematoxylin and eosin and SAH-induced damage was analyzed by terminal deoxynucleotidyl transferase dUTP nick end labeling of apoptotic cells. Specimens were stereologically examined to determine saliva-filled total vesicle volume (TVV) per cubic meter; vasospasm index (VSI) based on wall/lumen ratio of parotid glands arteries, and degenerated neuron density (DND) of glossopharyngeal ganglia. Results: The mean oral temperature was 36.9°C. In the control group, mean values were as follows: SC, 46±8 mm2; DND, 19±4/mm3; VSI, 1.065±0.049; and TVV, (780±1187) × 106/µm3. In the sham group, mean values were as follows: SC, 31±6 mm2; DND, 98±23/mm3; VSI, 1.67±0.32; and TVV, (617±110) × 106/µm3. In the low hyperthermia SAH group, mean values were as follows: SC, 16±5 mm2; DND, 1520±261/mm3; VSI, 2.12±0.21, and TVV, (314±98) × 106/µm3. In the high hypothermia SAH group, mean values were as follows: SC, 9±2 mm2; DND, 3210±912/mm3; VSI, 3.18±0.30; and TVV, (432±99) × 106/µm3. Conclusions: Decreased salivary secretion due to secretory gland atrophy originated from ischemia-induced GPN network degeneration at the brainstem, which may be responsible for cranial hyperthermia following SAH.
- 1 February 2021
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 87 (2) , 144-146
Barotrauma in mechanically ventilated patients with COVID-19
Barotrauma in mechanically ventilated patients with COVID-19 - Minerva Anestesiologica 2021 February;87(2):144-6 - Minerva Medica - Journals
- 1 February 2021
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 87 (2) , 144-146
Barotrauma in mechanically ventilated patients with COVID-19
Barotrauma in mechanically ventilated patients with COVID-19 - Minerva Anestesiologica 2021 February;87(2):144-6 - Minerva Medica - Journals
- Open Access
- 26 December 2020
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 71 (1) , 79-83
Helmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report
- 26 December 2020
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 71 (1) , 79-83
Open AccessHelmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report
- Open Access
- 29 September 2020
- Published by Heighten Science Publications Corporation in International Journal of Clinical Anesthesia and Research
- Vol. 4 (1) , 013-018
A comparison of complications associated with nutrition between the patients receiving enteral or parenteral in the intensive care unit
The aim of this study was to investigate and compare the complications including infection and mortality associated with enteral and parenteral nutrition on patients in the ICU of a university hospital. In this study, a total of 100 patients who were under follow-up in the ICU for two years were examined. In our study, demographic characteristics, the reason for admission, comorbidity, initial ICU laboratory values, morbidity and mortality during the follow-up period of the patients who only received enteral nutrition (EN) or parenteral nutrition (PN) were evaluated, and the results between two were compared as well as evaluating the complications within the groups. The comparison of the reason for admission between the EN and PN groups showed that surgical reasons were significantly higher in the PN group. Nosocomial infections, the presence of infection and the development of sepsis were significantly higher in the EN group. The 28-day mortality rate was higher in the PN group compared to the EN group. The length of stay in the ICU and on mechanical ventilation was longer in the EN group. There was no significant difference in the 28-day mortality, readmission to the ICU and repeated endotracheal intubation between the two groups. Because there is no statistical difference between EN and PN groups in point of infection and mortality, we conclude that the length of stay in the ICU and reason for admission play a more crucial role in the development of infection and on mortality rather than enteral or parenteral nutrition route.
- 29 September 2020
- Published by Heighten Science Publications Corporation in International Journal of Clinical Anesthesia and Research
- Vol. 4 (1) , 013-018
Open AccessA comparison of complications associated with nutrition between the patients receiving enteral or parenteral in the intensive care unit
The aim of this study was to investigate and compare the complications including infection and mortality associated with enteral and parenteral nutrition on patients in the ICU of a university hospital. In this study, a total of 100 patients who were under follow-up in the ICU for two years were examined. In our study, demographic characteristics, the reason for admission, comorbidity, initial ICU laboratory values, morbidity and mortality during the follow-up period of the patients who only received enteral nutrition (EN) or parenteral nutrition (PN) were evaluated, and the results between two were compared as well as evaluating the complications within the groups. The comparison of the reason for admission between the EN and PN groups showed that surgical reasons were significantly higher in the PN group. Nosocomial infections, the presence of infection and the development of sepsis were significantly higher in the EN group. The 28-day mortality rate was higher in the PN group compared to the EN group. The length of stay in the ICU and on mechanical ventilation was longer in the EN group. There was no significant difference in the 28-day mortality, readmission to the ICU and repeated endotracheal intubation between the two groups. Because there is no statistical difference between EN and PN groups in point of infection and mortality, we conclude that the length of stay in the ICU and reason for admission play a more crucial role in the development of infection and on mortality rather than enteral or parenteral nutrition route.
- Open Access
- 2 September 2020
- Published by Peertechz Publications Private Limited in Journal of Surgery and Surgical Research
- Vol. 6 (2) , 133-136
Anesthesia and analgesia for shoulder surgery
The shoulder is very important for a vertical body position and cosmetic appearance particularly in women. The shoulder joint has the largest motion range of all joints in the human body.
- 2 September 2020
- Published by Peertechz Publications Private Limited in Journal of Surgery and Surgical Research
- Vol. 6 (2) , 133-136
Open AccessAnesthesia and analgesia for shoulder surgery
The shoulder is very important for a vertical body position and cosmetic appearance particularly in women. The shoulder joint has the largest motion range of all joints in the human body.